期刊文献+

脱氧核酶抑制耐药基因mecR1的表达逆转MRSA耐药性 被引量:5

Restoration of antibiotic susceptibilitly of MRSA by blocking mecR1 through deoxyribozyme
下载PDF
导出
摘要 目的探讨脱氧核酶抑制耐甲氧西林金黄色葡萄球菌(M RSA)耐药基因m ecR1的表达对M RSA耐药性的影响。方法设计、合成特异性针对耐药基因m ecR1m RNA的硫代脱氧核酶,将其导入细菌,通过半定量RTP-CR观察脱氧核酶对耐药基因m ecR1及其下游基因m ecA表达的抑制作用,并通过平板克隆形成实验观察脱氧核酶对M RSA耐药性的影响。结果加入脱氧核酶后培养的M RSA,m ecR1与m ecA的m RNA表达水平较对照组显著降低(P<0.01),在含苯唑西林(6m g L/)的M H-琼脂培养基表面生长的菌落单元数也低于对照组(P<0.01)。结论特异性抗m ecR1脱氧核酶阻断耐药基因m ecR1m-ecA的表达,可以部分恢复M RSA对抗生素的敏感性。 Objective To investigate the effects of DNAzyme on drug-resistant gene mecR1 expression in methicillin-resistant Staphylococcus aureus(MRSA). Methods Specific DNAzyme to mecR1 mRNA was designed and synthesized. After DNAzyme was introduced into MRSA, drug-resistant characters of MRSA were evaluated by plate cloning formation experiment. The inhibition effects of DNAzyme on the expressions of drug-resistant gene mecR1 and its downstream gene mecA were observed by RT-PCR. Results Colony forming units(CFU)of MRSA incubated with DNAzyme on the MH agar added oxacillin (6mg/L) were less than those of control group(P〈0.01). Levels of mecR1 and mecA mRNA of the DNAzyme groups were lower than those of the control group (P〈0.01). Conclusion Antibiotic sensitivity on MRSA may be partially restored by DNAzyme which blocks the expressions of drug-resistant genes mecR1-mecA.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2006年第3期144-148,共5页 Chinese Journal of Antibiotics
基金 国家自然科学基金(30271556) 全军医药卫生科研基金资助项目(02M008)
关键词 耐甲氧西林金黄色葡萄球菌 脱氧核酶 耐药性 基因表达 Methicillin-resistant Staphylococcus aureus(MRSA) DNAzyme Drug-resistance Gene expression
  • 相关文献

参考文献19

  • 1Hryniewicz W. Epidemiology of MRSA [J]. Infection, 1999,27 (Suppl 2) :S13
  • 2赵先颖,徐元宏,江晓平.医院感染葡萄球菌菌种变迁与耐药性近况[J].中国微生态学杂志,2003,15(1):40-41. 被引量:40
  • 3Lowy F D. Antimicrobial resistance: the example of Staphylococcus aureus [J]. J Clin Invest,2003,111(9):1265
  • 4Mallorqui-Femandez G, Marrero A, Garcia-Pique S, et al.Staphylococcal methicillin resistance: fine focus on folds and functions [J]. FEMS Microbiol Lett,2004,235(1) : 1
  • 5Moelledng R C. Jr. Antibiotic resistance : Lessons for the future[J]. Clin infect Dis, 1998,27(Suppl 1) :S135
  • 6Breithaupt H. The new antibiotics [J]. Nat Biotechnol, 1999,17 (12) : 1165
  • 7Jaffe R I, Lane J D, Albury S V, et al. Rapid extraction from and direct identification in clinical samples of methicillin-resistant staphylococci using the PCR [J]. J Clin Microbiol, 2000,38(9) :3407
  • 8Hiramatsu K, Asada K, Suzuki E, et al. Molecular cloning and nuchotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus(MRSA) [J]. FEBS Lett, 1992,298(2 - 3) : 133
  • 9National committee for clinical laboratory standards. Performance standards for antimicrobioal susceptibility testing: four-teenth informational supplement; approved standard M100-S14[S]. Wayne, PA:NCCLS, 2004:35
  • 10莫岚,王其南,李崇智,刘鸿渝.不同的培养条件对检出耐甲氧西林葡萄球菌的影响[J].中国抗生素杂志,1997,22(5):353-355. 被引量:1

二级参考文献36

  • 1[2]Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance [J]. Clin Infect Dis, 1996;23(2) :255 - 9
  • 2[3]Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infectious in United States hospitals: a three-year analysis[J]. Clin infect Dis,1999;29(2) :239 - 44
  • 3[4]Soriano A, Martinez JA, Meusa J, Marco F, Almela M,Moreno-Martinez A, et al. Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia [J]. Clin Infect Dis, 2000;30(2):368 - 73
  • 4[5]Boyce JM. Should we vigorously try to contain and control methicillin-resistant Staphylococcus aureus[J]? Infect Control Hosp Epidemiol, 1991; 12(1) :46 - 54
  • 5[6]Pujol M, Pena C, Pallares R, Ariza J, Ayats J, Dominguez MA, et al. Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible straius[J]. Am J Med, 1996; 100(5):509- 16
  • 6[7]Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus[J]. Arch Intern Med, 1998;158(2): 182 - 9
  • 7[8]Zhang HZ, Hackbarth CJ, Chansky KM, Chambers HF. A proteolytic transmembrane signaling pathway and resistance to betalactams in staphylococci [J]. Science, 2001; 291 (5510): 1962-5
  • 8[9]Archer GL, Bosilevac JM. Signaling antibiotic resistance in Staphylococci[J]. Science, 2001 ;291(5510): 1915 - 6
  • 9[10]Sun LQ, Cairns MJ, Saravolac EG, Baker A, Gerlach WL.Catalytic Nucleic Acids: From Lab to Applicatious [J]. Pharmacol Rev, 2000;52(3) :325 - 47
  • 10[11]Sun LQ, Cairns M J, Gerlach WL, Witherington C, Wang L,King A. Suppression of Smooth Muscle Cell Proliferation by a cmyc RNA-cleaving Deoxyribozyme[J]. J Biol Chem, 1999;274(24): 17236 - 41

共引文献192

同被引文献141

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部